GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (HKSE:02359) » Definitions » Other Operating Expense

Wuxi AppTec Co (HKSE:02359) Other Operating Expense : HK$2,022 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co Other Operating Expense?

Wuxi AppTec Co's Other Operating Expense for the three months ended in Mar. 2024 was HK$-13 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was HK$2,022 Mil.

Wuxi AppTec Co's quarterly Other Operating Expense increased from Sep. 2023 (HK$-1,133 Mil) to Dec. 2023 (HK$2,088 Mil) but then declined from Dec. 2023 (HK$2,088 Mil) to Mar. 2024 (HK$-13 Mil).

Wuxi AppTec Co's annual Other Operating Expense increased from Dec. 2021 (HK$1,522 Mil) to Dec. 2022 (HK$1,850 Mil) and increased from Dec. 2022 (HK$1,850 Mil) to Dec. 2023 (HK$1,967 Mil).


Wuxi AppTec Co Other Operating Expense Historical Data

The historical data trend for Wuxi AppTec Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuxi AppTec Co Other Operating Expense Chart

Wuxi AppTec Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 951.56 1,372.89 1,522.06 1,849.87 1,966.94

Wuxi AppTec Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -47.16 1,079.26 -1,132.63 2,087.85 -12.88

Wuxi AppTec Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$2,022 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuxi AppTec Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuxi AppTec Co (HKSE:02359) Business Description

Traded in Other Exchanges
Address
288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices. Its segments comprise China-based laboratory services; U.S.-based laboratory services; Clinical research and other CRO services; CDMO services; and Others. The majority of revenue gets derived from China-based laboratory services that include small molecules discovery, such as synthetic chemistry, medicinal chemistry, analytical chemistry, biology, drug metabolism and pharmacokinetics (DMPK)/absorption, distribution, metabolism, and excretion (ADME), toxicology and bioanalytical services.
Executives
Jpmorgan Chase & Co.
Blackrock, Inc. 2201 Interest of corporation controlled by you
Schroders Plc 2102 Investment manager
The Capital Group Companies, Inc. 2201 Interest of corporation controlled by you
Citigroup Inc. 2201 Interest of corporation controlled by you
The Goldman Sachs Group, Inc.
Brown Brothers Harriman & Co. 2502 Approved lending agent
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Fil Limited 2201 Interest of corporation controlled by you
Computershare Hong Kong Trustees Limited 2301 Trustee
Bank Of America Corporation
Hsbc Holdings Plc 2201 Interest of corporation controlled by you
Qatar Investment Authority
Al Rayyan Holding Llc

Wuxi AppTec Co (HKSE:02359) Headlines

No Headlines